• Restoring tissue regeneration in patients with visceral Graft versus Host Disease.

    Restoring tissue regeneration in patients with visceral Graft versus Host Disease.

  • Restoring tissue regeneration in patients with visceral Graft versus Host Disease.

    Restoring tissue regeneration in patients with visceral Graft versus Host Disease.

Project
Project

RETHRIM is a research consortium interested in the potential use of MSC to treat GvHD

Partners
Partners

RETHRIM combines experts in the field of hematology, regenerative medicine and assay development

Science
Science

RETHRIM will conduct a clinical trial and develop predictive assays for patient eligibility and MSC potency

RETHRIM

RETHRIM is an EU sponsored research consortium that has initiated a phase III clinical trial to investigate the usefulness of Mesenchymal Stromal Cells for the treatment of Graft-versus-Host-Disease

RETHRIM receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643580

.